- Home
- EXEL vs JHX Comparison
EXEL vs JHX Comparison
Compare EXEL & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- JHX
- Stock Information
- Founded
- EXEL 1994
- JHX 1888
- Country
- EXEL United States
- JHX Ireland
- Employees
- EXEL 1147
- JHX N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- JHX Building Materials
- Sector
- EXEL Health Care
- JHX Industrials
- Exchange
- EXEL Nasdaq
- JHX Nasdaq
- Market Cap
- EXEL 10.4B
- JHX 11.3B
- IPO Year
- EXEL 2000
- JHX N/A
- Fundamental
- Price
- EXEL $38.31
- JHX $29.02
- Analyst Decision
- EXEL Buy
- JHX Strong Buy
- Analyst Count
- EXEL 21
- JHX 7
- Target Price
- EXEL $43.65
- JHX $33.67
- AVG Volume (30 Days)
- EXEL 4.0M
- JHX 4.0M
- Earning Date
- EXEL 07-28-2025
- JHX 08-19-2025
- Dividend Yield
- EXEL N/A
- JHX N/A
- EPS Growth
- EXEL 81.76
- JHX N/A
- EPS
- EXEL 2.08
- JHX 0.98
- Revenue
- EXEL $2,230,005,000.00
- JHX $3,877,500,000.00
- Revenue This Year
- EXEL $9.88
- JHX $14.38
- Revenue Next Year
- EXEL $12.59
- JHX $17.84
- P/E Ratio
- EXEL $18.45
- JHX $40.60
- Revenue Growth
- EXEL 10.73
- JHX N/A
- 52 Week Low
- EXEL $25.12
- JHX $19.72
- 52 Week High
- EXEL $49.62
- JHX $43.57
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- JHX 62.03
- Support Level
- EXEL $37.01
- JHX $27.81
- Resistance Level
- EXEL $38.78
- JHX $29.83
- Average True Range (ATR)
- EXEL 1.12
- JHX 0.72
- MACD
- EXEL 0.07
- JHX 0.22
- Stochastic Oscillator
- EXEL 83.79
- JHX 81.13
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.